Clinical Trial Update: Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia [NA]

View source ↗

Summary

A clinical trial update evaluating two different doses of rabbit ATG-Fresenius with cyclosporin for acquired aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• ATG-Fresenius (anti-thymocyte globulin)
• Cyclosporin (cyclosporine)

Snippet

Sponsor: National Institute of Blood Disease Center, Pakistan | Conditions: Aplastic Anemia | NA | Status: UNKNOWN